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Brain aging and aging-related neurodegenerative disorders are major health challenges
faced by modern societies. Brain aging is associated with cognitive and functional decline
and represents the favourable background for the onset and development of dementia.
Brain aging is associated with early and subtle anatomo-functional physiological changes
that often precede the appearance of clinical signs of cognitive decline. Neuroimaging
approaches unveiled the functional correlates of these alterations and helped in the
identification of therapeutic targets that can be potentially useful in counteracting
age-dependent cognitive decline. A growing body of evidence supports the notion that
cognitive stimulation and aerobic training can preserve and enhance operational skills
in elderly individuals as well as reduce the incidence of dementia. This review aims at
providing an extensive and critical overview of the most recent data that support the
efficacy of non-pharmacological and pharmacological interventions aimed at enhancing
cognition and brain plasticity in healthy elderly individuals as well as delaying the cognitive
decline associated with dementia.
Keywords: brain aging, neuronal plasticity, cognitive enhancing drugs, non-pharmacological interventions, cogni-
tive enrichment
INTRODUCTION
Brain aging is associated with cognitive and functional decline
and represents the favorable background for the onset and
development of Alzheimer’s disease (AD). AD is becoming
a major socio-economical challenge for society (Hurd et al.,
2013). Early use of imaging and biological markers can iden-
tify at-risk for AD subjects decades before the appearance
of cognitive decline. It is therefore imperative to act dur-
ing this extended pre-clinical phase and promote endogenous
responses in brains that still have a large cognitive reserve
and optimal levels of neural plasticity. Beside pharmacolog-
ical intervention, a great deal of interest resides on ways
that allow modulation of brain plasticity in the elderly by
acting on cognitive stimulation and/or aerobic exercise. Cog-
nitive enrichment as well as physical activity can in fact pro-
mote neural plasticity, increase neurotrofism and reduce AD
incidence. This review aims at providing an extensive and
critical overview of the most recent data that support the
efficacy of non-pharmacological and pharmacological inter-
ventions aimed at enhancing cognition in healthy elderly
individuals. This line of intervention can be also critical in
delaying the cognitive decline associated with dementia or
other widespread neurodegenerative conditions like Parkinson’s
disease (PD).
COGNITIVE AND NEURAL RESERVE
The central nervous system (CNS) is a highly dynamic structure
that undergoes continuous functional remodeling. Salient experi-
ence promotes widespread changes within neuronal circuits and
brain areas, a process that results in the harmonization of cogni-
tive skills that are set to meet and cope with demands of everyday
life. In this context, CNS plasticity is the ability to adopt func-
tional or structural responses (Ganguly and Poo, 2013) aimed at
promoting successful adaptive behavior (Xerri, 2008; Wittenberg,
2010). Activity-dependent neural plasticity is not only required
for optimal brain development but is also occurring through
adulthood and senescence (Buonomano and Merzenich, 1998;
Feldman and Brecht, 2005; Feldman, 2009). Plasticity requires a
complex process of molecular, structural, and functional integra-
tions that are carried out in neurons, glia, and subcellular com-
partments like dendrites, spines, and synapses. These biochemical
and morphological changes go along with spatiotemporal syn-
chronization of large neuronal populations across different brain
regions. While neuronal plasticity has been studied mostly in the
neocortex and hippocampus, it is important to underline that
the phenomenon is common to almost all the CNS structures.
The last two decades have produced a dramatic increase in the
availability of techniques that allow the extensive investigation of
CNS from its subcellular components to neural circuits.
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Advancements in fluorescent microscopy, molecular biology,
and electrophysiological techniques have helped to unravel many
molecular determinants of neuronal plasticity. On the other
hand, the availability of neuroimaging tools such as functional
magnetic resonance imaging (fMRI), positron emission tomogra-
phy (PET), and magnetoencephalography (MEG) have enhanced
the capability to detect spatiotemporal patterns of brain acti-
vation that occur within networks, nodes, and neuronal path-
ways (Pascual-Leone et al., 2005; Raichle and Mintun, 2006;
Grefkes and Ward, 2014). These technical advancements, along
with the notion that the aging brain retains the capacity to
reorganize its morphological and functional architecture, have
promoted strong interest and leaps forward in the knowledge
of the physiology of the aging brain and aging-related cognitive
processes as well as in the exploration of strategies aimed at
enhancing or maintaining cognitive skills in the elderly. This area
of investigation is particularly relevant as molecular, structural
and functional derangement of physiological aging represents the
pathological pabulum for the onset and development of neu-
rodegenerative processes that underlay conditions like dementia
or PD.
Cognitive reserve is the concept that has been proposed to
explain the functional adaptation occurring in conditions that are
associated with brain damage, but where structural impairment
does not translate in patent cognitive deficits. When discussing
this process, a clear distinction should be made between brain
reserve and cognitive reserve. Brain reserve refers to the amount
of preserved CNS “hardware”, namely the integrity of synapses,
dendrites, neurons, glia, and pathways while cognitive reserve
indicates the CNS “software”, in short the brain capability to reor-
ganize its activity by setting in motion compensatory cognitive
mechanisms. Thus, the cognitive reserve concept imposes to shift
the attention from brain morphological integrity to functioning
(Stern, 2009).
Despite recent great progress occurring in the field, the relative
contribution of cognitive and brain reserve to the maintaining of
brain functioning throughout aging is not completely clear. The
two processes interplay and it is well known that rehabilitative
interventions can positively act on both phenomena (Voss et al.,
2013).
Cognitive reserve is positively influenced by educational, envi-
ronmental, nutritional as well as genetic factors (Mora, 2013). The
modulation of cognitive reserve greatly influences the vulnera-
bility to dementia and affects the clinical course of the disease.
Cognitive reserve has been indicated as a resource to be has tapped
on in AD patients who despite the presence of large amount of
AD-related pathology show relative paucity of clinical symptoms
and signs. The process is thought to require the formation of
new synapses as well as the plastic remodelling and functioning
of brain networks (Amieva et al., 2014).
The drawback is that these patients can go undetected for long
time and then, when exhaustion of the cognitive reserve occurs,
eventually show a precipitous cognitive decline (Amieva et al.,
2014). This rapid progression is considered to be related to high
pathological loads that were compensated by a high cognitive
reserve that eventually have been subdued and collapsed (Wilson
et al., 2004; Amieva et al., 2014).
Neuroimaging evidence support this idea and indicate that
AD patients with greater cognitive reserve often show underlying
greater AD-related pathology. In a subset of AD patients, PET
measurements of resting regional cerebral blood flow (rCBF) have
shown an inverse relationship between resting cerebral blood
volume (rCBV) and years of education (Friedland et al., 1985;
McGeer et al., 1990). These studies indicate that patients with
high levels of education manifest more pronounced reductions in
parieto-temporal rCBV when compared to less educated subjects
presenting similar clinical features. Similar results were observed
in studies evaluating protective effects of rehabilitative activities
(Stern et al., 1995; Scarmeas et al., 2003). fMRI studies have
revealed patterns of brain network activity that supports the con-
cept of cognitive reserve (Stern et al., 2005). Neuroimaging studies
revealed that elderly people engage additional brain regions to
compensate for impaired functioning (Fjell et al., 2014). For
instance, upon completion of a memory task, experimental data
indicate that, compared to young people, elderly individuals
show increased recruitment of the prefrontal cortex (PFC), a
process that possibly compensates for the reduced activity of brain
regions that support visual processing of information (Ansado
et al., 2013). The phenomenon has been labelled as “age-related
posterior-anterior shift”, or PASA (Davis et al., 2008). PASA seems
to optimize cognition by inducing the inhibition of pre-potent
responses (Corbetta et al., 2008; Vincent et al., 2008; Vallesi et al.,
2011). Moreover, a recent study indicates that subjects performing
attention tasks show an increased activity in bilateral PFC that
positively correlates with enhanced performance (Davis et al.,
2012).
NON-PHARMACOLOGICAL INTERVENTIONS
Age-related modulations and variations of cognitive and neural
systems are dynamic and not irreversible processes. Physical or
cognitive training can promote positive and lasting cognitive
effects in elderly people and behavioral gains that may translate
in more efficient procedural skills that help to cope with daily life
activities. Non-pharmacological intervention can be divided in
two approaches: aerobic training and cognitive stimulation (Jack,
2011; Vaughan et al., 2012).
AEROBIC TRAINING
Aerobic exercise is associated with increased preservation of
cognitive functions (Colcombe et al., 2004). Exercise induces
a cascade of molecular and sub/cellular processes that favor
angiogenesis, neurogenesis, synaptogenesis as well as enhanced
production of neurotrophins specially, the increased synthesis and
release of brain-derived neurotrophic factor, BDNF (Deslandes
et al., 2009; Coelho et al., 2013). The role of neurotrophins
is crucial as decreases in BDNF levels are associated with age-
related neuronal loss and BDNF reduction is also observed in
patients affected by neurodegenerative or psychiatric disorders.
Aerobic exercise elevates BDNF concentrations, increases hip-
pocampal volumes (with the control group showing a reduction
of volume of ∼1.4% while the trained group showed a volume
increase of ∼2% over a 1-year period), and promotes better
cognitive functioning in terms of executive functions, thereby
suggesting that the trophin is a critical factor in mediating the
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protective and cognitive effects of this type of training (Erickson
et al., 2013). Regular aerobic exercise improves executive function,
attention, processing speed, memory, learning processes, and
helps to preserve mental abilities throughout life span (Colcombe
and Kramer, 2003; Curlik and Shors, 2013; Dresler et al., 2013).
Exercise is also beneficial for subjects suffering from Mild Cog-
nitive Impairment (MCI) or early-stage dementia (Smith et al.,
2010).
Longitudinal studies suggest that engagement in exercise at
young age leads to better cognitive performance upon senescence.
The process seems to follow a dose- response effect as, in anal-
ogy with pharmacological intervention, more robust effects are
obtained in individuals who in their youth have exercised more
intensively (Middleton et al., 2010). Exercise appears to prefer-
entially target selected brain regions and/or cognitive domains
(Kramer et al., 2003; Colcombe et al., 2006; Erickson et al., 2013).
Neuroimaging supports the idea of greater effects of exercise
in the prefrontal and medial temporal cortices (Berchicci et al.,
2013). The hippocampus appears to be particularly sensitive to
exercise with trophic responses leading to increased hippocampal
volume by∼2% in subjects undergoing training (Kerr et al., 2010;
Erickson et al., 2011, 2013).
Overall, exercise-driven effects on specific cognitive domains
like executive functions match morpho-functional changes in
related brain regions (hippocampus, PFC, and basal ganglia)
and neural networks. Elderly people who regularly exercise show
brain volumes increases by ∼2% in these critical areas while age-
matched individuals who are less physically active undergo a 1.4%
decrease in volumes (Erickson et al., 2010, 2011; Esposito et al.,
2013).
COGNITIVE TRAINING
Cognitive stimulation by employing interventions that make use
of ecological or virtual environments is also effective to compen-
sate age-related cognitive decline (Curlik and Shors, 2013; Park
and Bischof, 2013). To date, several types of cognitive trainings
are available. Several programs are aimed at improving memory
(Richmond et al., 2011; Dresler et al., 2013), learning (Bailey et al.,
2010), attention (Mozolic et al., 2011), executive functions (Basak
et al., 2008), fluid intelligence (Jaeggi et al., 2008), mnemonic
techniques, or global cognition (Klusmann et al., 2010).
Shedding some light on the molecular targets of cognitive
stimulation, preclinical models have shown that enriched envi-
ronments improve cognitive performances by inducing enhanced
expression of genes encoding for neurotrophins or promoting
synaptogenesis, dendrite formation and arborization (van Praag
et al., 2000; Fratiglioni et al., 2004). The same mechanisms also
occur in brains of elderly people (Mora, 2013).
Neuroimaging data show that memory-targeted training can
induce positive fMRI changes as well as modification in cortical
thickness of hippocampal subfields and increases in the volumetry
of left hippocampal subregions like the CA3, CA4, and dentate
gyrus (Engvig et al., 2012). Memory training also increases the
thickness of the right fusiform and lateral orbitofrontal cortex, a
phenomenon that has been positively correlated with enhanced
memory performances (Engvig et al., 2010). Unfortunately, only
few fMRI studies have unveil functional connectivity effects
associated with cognitive intervention (Burhan et al., 2012; Engvig
et al., 2014).
PC-BASED TRAINING
Video games are not just teenager leisure material, they are
gaining a place in the field of rehabilitation as tools to improve
cognition in the elderly (Clark et al., 1987; Dustman et al.,
1992; Goldstein et al., 1997; Basak et al., 2008). Results in this
area of intervention are, however, often contradictory. Computer-
based cognitive training for 6 months has been shown to stimu-
late multi-domain abilities like immediate memory and delayed
memory or language (Miller et al., 2013). Game-based cognitive
training, on the other hand, has shown no group effects on
visuo-spatial navigational abilities and memory, though attention
improvements have been found (Whitlock et al., 2012).
Interestingly, a recent study showed that computerized train-
ing targeted at amelioration of reaction times, inspection times,
short-term memory for words, executive functions, visuo-spatial
acuity, arithmetic competence, visuo-spatial memory, visual scan-
ning, visual discrimination, and n-back working memory pro-
moted no enhancement in these domains, but resulted in global
improvement of processing speed (Simpson et al., 2012). The
phenomenon is known as transfer effect. Moreover, evidence
suggest that computer games designed to improve processing
speed can enhance short-term memory and attention (Szelag and
Skolimowska, 2012).
A very intriguing recent study has shown that cognitive capa-
bilities can be significantly rejuvenated in the elderly (Anguera
et al., 2013). Upon playing a video game targeted at increasing
multitasking performance (a domain that show a physiological
age-dependent decline), study subjects showed benefits not just
in multitasking but also in untrained domains like sustained
attention and working memory. The behavioral result was asso-
ciated EEG evidence that show enhanced midline frontal theta
power and frontal–posterior theta coherence in the trained group.
More importantly, by simply undergoing a training period that
spanned for just 12 h over a 4 week period, elderly subjects showed
improved multitasking capability and matched performance lev-
els of untrained young (20-year-old) subjects. Improved cognitive
performances were maintained for 6 months after suspension of
training, thereby suggesting long-lasting functional effects. Thus,
the study supports the idea that age-related decline can be, not
only halted, but actually reversed.
The field of PC-based cognitive training is still in its infancy,
but, nevertheless, promising. Studies have started to analyze and
debug areas that can potentially hamper the efficacy of this type
of intervention. For instance, off the shelf, commercially available
games appear to be less effective than personalized games (Peretz
et al., 2011). Unfortunately, online games designed to enhance
cognition in the elderly have generally failed mostly because of
lack of motivation or ceiling effects in trainees who were already
highly functioning and/or highly exposed to digital settings like
virtual reality environments and games (Bozoki et al., 2013).
Factors greatly affecting the cognitive outcome of PC-based train-
ings are the intensity and frequency of exposure to the training;
however, a clear cut linear relationship between these factors and
the cognitive output has, surprisingly, been difficult to be drawn
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(Whitlock et al., 2012; Wild-Wall et al., 2012). Better study designs
are therefore needed (Green and Bavelier, 2008; Nouchi et al.,
2012; Whitlock et al., 2012). Finally, in a recent comparative
study, a custom-made computerized intervention was found to
improve overall memory and attention performances in a group
of elderly subjects. The study showed that training effects were
still present 3 month after training withdraw (Zelinski et al.,
2011).
COMBINED TRAINING
Interest in multimodal interventions has been increased in recent
years. Evidence, unfortunately still too few, suggest that strategies
that combine aerobic training and cognitive stimulation have a
significant synergistic value (Schneider and Yvon, 2013).
In a recent study, healthy elderly subjects were exposed to four
different training conditions (Shatil, 2013). The first group was
exposed to cognitive training, the second group engaged itself in
moderate aerobic activity, the third group followed a combination
of cognitive and aerobic training, while the control group was
simply exposed to book-reading. Results of the study indicated
that the third group, exposed to combined training, showed the
best improvement in eye-hand coordination, working memory,
long-term memory, and reaction times.
Interesting effects were also found in case of PC-based train-
ing combined with exercise. Cycling sessions performed in a
virtual reality environment enhanced executive functions more
effectively that regular cycling in a gym on stationary bikes
(Anderson-Hanley et al., 2012). Positive effects of trained cyber-
cyclists correlated with increase of BDNF. Important effects,
in the cybercycling group, were also seen in MCI subjects. In
this group, training reduced by 23% AD conversion (Anderson-
Hanley et al., 2012). Another study (Maillot et al., 2012) found
a significant improvement in executive control and processing
speed after a 12 week aerobic training that employed the Nintendo
Wii sports software console.
Other studies have supported the idea of the synergistic value
of combining exercise and cognitive trainings to promote memory
performance (Fabre et al., 2002; Oswald et al., 2006). Unfor-
tunately, no data are available to verify whether these training-
driven benefits translate in better performances in daily living
activities. A previous study, from our group, has tried to fill the
gap (Pieramico et al., 2012). We evaluated effects of 6-month
combination training on cognition, functional connectivity and
daily living activities. Thirty healthy elderly divided in two groups
of 15 subjects were exposed to either no changes in their daily
living routine (control group) or to a combination training con-
sisting in exposure to cognitive, motor, and sensorial stimulations
(trained group). Groups were evaluated, before and after the end
of the training period, with neuropsychological and occupational
tests, resting state fMRI and analysis of cortical thickness. Com-
bination training improved cognitive and occupational perfor-
mances, reorganized the functional connectivity of Default Mode
(DMN) and Dorsal Attention (DAN) networks, and promoted
lower cortical thinning in several brain regions (Pieramico et al.,
2012). Interestingly, analysis of dopamine-related genes indicated
that carriers of DRD3 ser9gly and catechol-O-methyltransferase
(COMT) val158met polymorphisms had the greatest benefits
from exposure to training, thereby suggesting a genetically-driven
susceptibility to the positive effects of this type of combined
intervention.
CRITICAL POINTS IN NON-PHARMACOLOGICAL
INTERVENTIONS
Many unknowns are still present when dealing with training
programs. For instance, the role played by intensity of inter-
vention and knowledge on which is the most beneficial set of
exercises to be employed are still largely unclear and missing. Also
uncertain is what concerns the specificity and selectivity of factors
that can promote significant, reproducible, and durable effects
on cognition. Few studies have investigated correlations between
frequency and duration of aerobic and cognitive trainings along
with the overall morpho-functional changes and effects on brain
functioning upon aging.
Furthermore, still not completely defined is for how long pos-
itive effects are maintained and therefore, robust well-designed
longitudinal studies are needed.
A limiting factor that should be not overlooked is individual
variability, an aspect that mandates more accurate customization
of any given set of intervention. For instance, in analogy with
the field of pharmacogenomics, a “cognitogenomic” approach, in
which genetic differences are explored in relation to response to
cognitive trainings, is definitely necessary (Pieramico et al., 2012).
PHARMACOLOGICAL INTERVENTIONS
Pharmacological intervention aimed at enhancing or maintaining
cognitive functions has been the focus of intensive research in
recent years (Lanni et al., 2008; Hussain and Mehta, 2011; Lynch
et al., 2011; Lynch and Mills, 2012; Wood et al., 2013; Urban and
Gao, 2014). An intuitive definition of Cognitive Enhancer Drugs
(CEDs) qualifies these molecules as able to enhance cognitive
skills; however, an exhaustive definition of CEDs is, perhaps,
not so simple. According to Lynch et coll., there is a need for
a “dimensional” system to successfully define and classify CED
candidates (Lynch and Gall, 2006; Lynch et al., 2011).
The first level, or dimension, is the target of action. Does
the CED candidate mainly act on “general” psychological states
like arousal or attentional level or does it work by potentiating
single and/or selective cognitive domains? If the action is global,
CED effects should be obtained through an optimization of
the processing and information flux that operate within several
brain nodes and networks. In case of selective activity, the drug
should instead affect only specific and distinct subsets of cognitive
domains.
Another important CED level/dimension is the neurobiologi-
cal one or, in other words, the molecular mechanisms of action.
Which neurotransmitter systems, receptor subpopulations, neu-
ronal circuits, and/or brain structures are modified by CED
activity?
Finally, a third dimensional level is represented by the dis-
tinction between drugs that enable to perform complex tasks
in a more rapid or efficient way (efficiency augmentation) vs.
molecules that promote enhanced performances (cognitive capa-
bility augmentation; Lynch, 2004; Lynch et al., 2011).
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In accordance with this systematization, CEDs can be classified
as drugs mainly acting on general or psychological aspects of
cognition, compounds aimed at potentiating more specific cog-
nitive domains or, at least in theory, drugs that are aiming at
enhancing the global cognitive capability of healthy and already
well performing individuals.
Most CED candidates are evaluated in preclinical models,
sets where standardized behavioral outcomes are easily assessed.
Although the translation of preclinical data in valid clinical out-
puts poses several limitations (see Sarter, 2006), animal models
remain extremely valuable to identify CED neurobiology (Roesler,
2011).
In that respect, methylphenidate and modafinil, are good
examples of a category of molecules that, across the board,
induces changes of psychological variables such as vigilance,
attention, and memory. Drug effects on arousal have been exten-
sively described; however, a recent study that examined human
subjects required to discriminate significant stimuli from distrac-
tors raised some question about the validity of the mechanism
(Agay et al., 2010). Methylphenidate increases attention or “vigi-
lance” by stimulating the cortical dopaminergic and noradrener-
gic transmission systems, a mechanism of action first described
in preclinical settings and then confirmed by PET in human
studies. Oral methylphenidate administration (0.25 mg/Kg) has
been shown to promote a 50% blockage of the dopamine trans-
porter (Volkow et al., 1998; Hannestad et al., 2010) and signifi-
cantly increase extracellular dopamine concentrations. However,
oral methylphenidate (at therapeutic ranges; 0.14 mg/kg) was
also shown to bind with high affinity to the norepinephrine
transporter. Methylphenidate-mediated effects on attention seem
quite specific for tasks that need sustained vigilance; however,
the drug appears to be less efficient when subjects are dealing
with situations with levels of complexity that require selective
attention (Advokat, 2010; Advokat et al., 2011). The compound
can also improve spatial working memory in healthy individuals
in conditions in which subjects are challenged with ex novo
spatial problems (Elliott et al., 1997). Interestingly, experimental
data confirmed drug-dependent improvements in spatial working
memory. However, the study indicated that such benefits only
occurred in subjects who were poorly performing at baseline,
thereby suggesting that the drug can work only when significant
amounts of cognitive reserve are available to be recruited (McGeer
et al., 1990).
Modafinil is another example of drugs operating on vigi-
lance or “attentional” states. The compound was first introduced
as agent that counteracts excessive sleepiness associated with
narcolepsy. Modafinil binds to forebrain dopamine transporters
(Volkow et al., 2009; Zolkowska et al., 2009; Andersen et al., 2010)
and promotes an increase in extracellular dopamine concentra-
tions. The molecule can also bind to norepinephrine transporters
in the human thalamus (Madras et al., 2006) and modulate
orexinergic neurons in the hypothalamus (Ishizuka et al., 2010).
Modafinil has been shown to promote marked increases in motor
activity in mice (Simon et al., 1995; Stone et al., 2002), how-
ever, the effects are modest in rats and monkeys (Edgar and
Seidel, 1997; Andersen et al., 2010). Finally, some studies have
indicated drug-dependent improvement in sustained attention in
modafinil-treated healthy subjects (Randall et al., 2005; Esposito
et al., 2013).
An important bias to be considered when evaluating CEDs
is represented by the fact that most studies, in animal models
(Béracochéa et al., 2002) or humans (Turner et al., 2003; Baranski
et al., 2004; Muller et al., 2004; Randall et al., 2005), are focused
on effects on attention and working memory while other cog-
nitive domains (such as long-term memory) are often neglected
(Minzenberg and Carter, 2008). CEDs that selectively act on
specific cognitive domains (memory and attention) belong to
two classes of drugs that target the fast excitatory synaptic trans-
mission responsible for communication within cortical networks.
The first class acts on nicotinic receptors (alpha7 and alpha4
agonists) and modulates glutamate release while the second one,
the ampakine family, facilitates fast glutamatergic transmission
by acting on α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid receptors (AMPAR).
The cholinergic system is involved in several important aspects
of cognitive functions including attention, learning, and memory.
Classical CEDs enhance brain cholinergic tone by inhibit-
ing acetylcolinecolinesterases (AChEIs), the enzymes responsible
of acetylcholine degradation. AChEIs (rivastigmine, donepezil,
galantamine) are approved for the treatment of AD patients;
however, these compounds have failed in patients suffering from
MCI (Raschetti et al., 2007), and very little data are available
on cognitive effects on healthy adults. Rivastigmine has been
shown to negatively affect episodic memory and improve motor
learning and visuospatial functions in healthy elderly subjects
(Wezenberg et al., 2005). Donepezil has produced mixed results,
the drug improves cognitive performance in healthy young sub-
jects (Yesavage et al., 2002) but has also been shown to cause atten-
tion and short-term memory deficits in healthy elderly subjects
(Beglinger et al., 2005). Selective α4β2 nicotinic receptor agonists
represent a new class of drugs acting on the cholinergic system
and found to induce attentional and cognitive improvements in
animal models (Howe et al., 2010). Agonists of α4β2 and α7
nicotinic receptors represent interesting examples of drugs that
can potentiate the prefrontal cholinergic activity. These drugs
promote an increase in fast glutamatergic transmission in the
cortex, thereby enhancing attentional processes (Dunbar et al.,
2007; Jiang and Role, 2008; Loughead et al., 2010). The pro-
posed mechanism of action for α4β2 agonists is based on the
hypothesis that the prefrontal cholinergic system plays a cru-
cial role in the detection of novel and relevant stimuli, thereby
increasing attentional performances (Bloem et al., 2014). The
drug leads to amplitude augmentation of signal-evoked cholin-
ergic transients when a relevant stimulus is administered to a
subject.
Ampakines are positive allosteric AMPAR modulators that
enhance fast excitatory transmission, promote induction and
enhanced strength of long-term potentiation (LTP; Lynch, 2002).
These compounds also increase the production of BDNF and
related proteins (Lauterborn et al., 2000, 2003; Legutko et al.,
2001; Lynch, 2002; O’Neill et al., 2004, 2005; Wezenberg et al.,
2007). A recent study has described a role for the CX546 ampakine
in promoting the proliferation and neuronal differentiation of
stem/progenitor cells originating from the subventricular zone
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(Schitine et al., 2012), thereby underlying the role of these
molecules in the differentiation of newborn neurons and in the
shaping of neuronal circuits. The CX929 ampakine has been
reported to promote LTP and counteract learning impairments
in mice models of neurodevelopmental disorders. In one study, a
5 day treatment with CX929 in a mouse model of the Angelman
syndrome, was reported to enhance fast EPSCs in hippocampal
slices and increase long-term memory scores by 50% (Baudry
et al., 2012). Ampakine are reported to improve performance in
monkeys challenged with complex cognitive tasks (Porrino et al.,
2005; Hampson et al., 2009) and brain imaging has demonstrated
increased activity in the frontal and temporal cortices upon
treatment (Porrino et al., 2005). The study revealed drug-induced
activation of the precuneus, a cortical area usually less involved
in task response (Porrino et al., 2005). This observation strongly
suggests that ampakine administration may promote functional
recruitment of additional brain areas, thereby modifying the
neural substrates of cognition. Unfortunately, no ampakines are
currently approved by FDA. The only molecule that reached clin-
ical trials is CX-717. The compound was evaluated in Phase I for
AD treatment but withdraw upon additional controversial results.
Potential novel candidates are nevertheless being investigated for
treatment of several neurologic and psychiatric disorders such as
PD, schizophrenia, autism, and Attention Deficit Hyperactivity
Disorder (ADHD).
Pharmaco-genomic approaches to be implemented for CED
development and administration represent a promising new
avenue in the field of cognitive augmentation. Traditionally
these approaches have been mainly focused on the identifica-
tion of genetic polymorphisms that can predict more effective
drug responses in subjects already affected by neuropsychiatric
disorders. However, in the past few years, studies have started
to unravel the pharmacogenomic basis of individual response
to CEDs occurring in healthy subjects. Factors to be consid-
ered are polymorphisms of genes regulating drug metabolizing
enzymes, transporters, and receptors. These factors may pro-
foundly influence the dose–response relationship to drugs (Roses,
2008). Differences in COMT genotypes (Val-Val vs. Met-Met)
have been associated with variability in working memory perfor-
mances and cognitive responses following amphetamine admin-
istration (Bilder et al., 2004). Apoliprotein E4 (apoE4), an allele
of apolipoprotein E, and a risk factor for AD, is an interesting
case. Quite paradoxically, ApoE polymorphism in young healthy
carriers (i.e., subjects who have therefore a higher risk of devel-
oping AD later on in life) have the tendency to perform decision-
making and prospective memory tasks better than, ApoE3 carriers
(who are instead protected, by virtue of this genotype, from AD;
Marchant et al., 2010).
CRITICAL POINTS IN PHARMACOLOGICAL INTERVENTIONS
A critical point in the clinical output of CEDs is represented
by the great variability of cognitive or behavioral responses of
healthy individuals to these drugs. Several studies have begun to
question whether such differences depend on genotypes and/or
baseline levels of cognitive function (Kimberg et al., 1997; Mehta
et al., 2000; Gibbs and D’Esposito, 2005; Frank and O’Reilly, 2006;
Cools et al., 2007). For example, dopaminergic drugs have been
shown to improve working memory only low performing subjects
(Gibbs and D’Esposito, 2006). Methylphenidate or bromocriptine
seem to improve working memory in low performers but impair
performance in subjects with high baseline spans (Kimberg et al.,
1997; Gibbs and D’Esposito, 2006). These contradictory results
have been explained by the presence of an inverted U-shaped rela-
tionship between cognitive performance and dopamine receptor
stimulation (Yerkes and Dodson, 1908). Indicating some poten-
tial neurobiological determinant of the phenomenon, dopamine
synthesis has been shown to be lower in in the caudate nucleus
of individuals with low working memory spans when com-
pared to synthesis in subjects with high spans (Cools et al.,
2008). Accordingly, subjects with low dopamine synthesis in the
basal ganglia performed better in reversal learning tasks after
bromocriptine administration when compared to treated subjects
who were already showing high basal ganglia synthesis (Cools
et al., 2009). Modafinil administration has also been shown to
have most effective cognitive effects in low performing subjects
at baseline (Randall et al., 2005; Finke et al., 2010; Esposito et al.,
2013).
Baseline cognitive levels also affect the cholinergic modulation
of cognition in healthy individuals. Donepezil increases cognition
of healthy subjects whose performance declined after sleep depri-
vation but the drug induced cognitive impairments in subject
without sleep loss (Chuah and Chee, 2008; Chuah et al., 2009).
Finally, it should be underlined that optimal brain functioning
results from a tight control of synaptic function, circuits remodel-
ing, and connectivity modulation. In response to extrinsic stimuli,
neurons accordingly change the strength of their connections
in order to avoid excessive excitation or inhibition (Pozo and
Goda, 2010). Therefore, CED-driven excessive connectivity can
be sometimes potentially problematic. In theory, increased excita-
tory synaptic transmission, along with reduced synaptic pruning,
may induce unregulated synaptic plasticity and neuronal circuit
overactivation, thereby promoting a low signal-to-noise ratio that
actually may lead to impaired cognition (Belmonte and Yurgelun-
Todd, 2003).
CONCLUSION AND FUTURE DIRECTIONS
In this review, we have summarized effects on cognition and brain
plasticity of non-pharmacological and pharmacological interven-
tions targeted on elderly individuals. The field is blooming but
many issues remain unresolved. Areas that are in great need of
advancement concern a better understanding of the role played
by genes in the modulation of senescence and/or response to
intervention. Disclosure of more detailed genetic and epigenetic
roadmaps will help the design and implementation of tailored
and personalized training programs. A more extensive imple-
mentation of “omics” (proteomics, lipidomics, metabolomics)
approaches in combination with neuroimaging will also promote
a better assessment of morpho-functional changes that are occur-
ring in the trained brain as well as whole body.
Recent progress in digital technologies leads to foresee, in
the near future, a more user-friendly implementation of train-
ings that can avoid personal computers and make instead use
of smartphones, virtual or augmented reality portable devices.
In that respect, the come of age of digitally-native generations
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will undoubtedly promote an extraordinary acceleration in that
direction.
All these, pharmacological and non pharmacological, inter-
ventions can be envisioned to be effective not only in maintaining
optimal levels of cognitive capabilities in healthy elderly individu-
als, but also as preventive measures to counteract the development
of AD or PD as well as therapeutic tools that can be employed in
the early stage of these neurodegenerative conditions.
ACKNOWLEDGMENTS
Stefano L. Sensi is supported by funds from the Italian Depart-
ment of Education (PRIN 2011) and the “Marisa Trampuz von
Langendorf ” Fellowship for Neuroscience.
REFERENCES
Advokat, C. (2010). What are the cognitive effects of stimulant medications?
Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD). Neu-
rosci. Biobehav. Rev. 34, 1256–1266. doi: 10.1016/j.neubiorev.2010.03.006
Advokat, C., Lane, S. M., and Luo, C. (2011). College students with and
without ADHD: comparison of self-report of medication usage, study
habits and academic achievement. J. Atten. Disord. 15, 656–666. doi: 10.
1177/1087054710371168
Agay, N., Yechiam, E., Carmel, Z., and Levkovitz, Y. (2010). Non-specific effects
of methylphenidate (Ritalin) on cognitive ability and decision-making of
ADHD and healthy adults. Psychopharmacology (Berl) 210, 511–519. doi: 10.
1007/s00213-010-1853-4
Amieva, H., Mokri, H., Le Goff, M., Meillon, C., Jacqmin-Gadda, H., Foubert-
Samier, A., et al. (2014). Compensatory mechanisms in higher-educated sub-
jects with Alzheimer’s disease: a study of 20 years of cognitive decline. Brain.
137(Pt 4), 1167–1175. doi: 10.1093/brain/awu035
Andersen, M. L., Kessler, E., Murnane, K. S., McClung, J. C., Tufik, S., and
Howell, L. L. (2010). Dopamine transporter-related effects of modafinil in
rhesus monkeys. Psychopharmacology (Berl) 210, 439–448. doi: 10.1007/s00213-
010-1839-2
Anderson-Hanley, C., Arciero, P. J., Brickman, A. M., Nimon, J. P., Okuma, N.,
Westen, S. C., et al. (2012). Exergaming and older adult cognition: a cluster
randomized clinical trial. Am. J. Prev. Med. 42, 109–119. doi: 10.1016/j.amepre.
2011.10.016
Anguera, J. A., Boccanfuso, J., Rintoul, J. L., Al-Hashimi, O., Faraji, F., Janowich,
J., et al. (2013). Video game training enhances cognitive control in older adults.
Nature 501, 97–101. doi: 10.1038/nature12486
Ansado, J., Marsolais, Y., Methqal, I., Alary, F., and Joanette, Y. (2013). The adaptive
aging brain: evidence from the preservation of communication abilities with
age. Eur. J. Neurosci. 37, 1887–1895. doi: 10.1111/ejn.12252
Bailey, H., Dunlosky, J., and Hertzog, C. (2010). Metacognitive training at home:
does it improve older adults’ learning? Gerontology 56, 414–420. doi: 10.
1159/000266030
Baranski, J. V., Pigeau, R., Dinich, P., and Jacobs, I. (2004). Effects of modafinil on
cognitive and metacognitive performance. Hum. Psychopharmacol. 19, 323–332.
doi: 10.1002/hup.596
Basak, C., Boot, W. R., Voss, M. W., and Kramer, A. F. (2008). Can training in a real-
time strategy video game attenuate cognitive decline in older adults? Psychol.
Aging 23, 765–777. doi: 10.1037/a0013494
Baudry, M., Kramar, E., Xu, X., Zadran, H., Moreno, S., Lynch, G., et al. (2012).
Ampakines promote spine actin polymerization, long-term potentiation and
learning in a mouse model of Angelman syndrome. Neurobiol. Dis. 47, 210–215.
doi: 10.1016/j.nbd.2012.04.002
Beglinger, L. J., Tangphao-Daniels, O., Kareken, D. A., Zhang, L., Mohs, R., and
Siemers, E. R. (2005). Neuropsychological test performance in healthy elderly
volunteers before and after donepezil administration: a randomized, controlled
study. J. Clin. Psychopharmacol. 25, 159–165. doi: 10.1097/01.jcp.0000155822.
51962.b4
Belmonte, M. K., and Yurgelun-Todd, D. A. (2003). Functional anatomy of
impaired selective attention and compensatory processing in autism. Brain Res.
Cogn. Brain Res. 17, 651–664. doi: 10.1016/s0926-6410(03)00189-7
Béracochéa, D., Celerier, A., Borde, N., Valleau, M., Peres, M., and Pierard, C.
(2002). Improvement of learning processes following chronic systemic admin-
istration of modafinil in mice. Pharmacol. Biochem. Behav. 73, 723–728. doi: 10.
1016/s0091-3057(02)00877-8
Berchicci, M., Lucci, G., and Di Russo, F. (2013). Benefits of physical exercise on the
aging brain: the role of the prefrontal cortex. J. Gerontol. A Biol. Sci. Med. Sci. 68,
1337–1341. doi: 10.1093/gerona/glt094
Bilder, R. M., Volavka, J., Lachman, H. M., and Grace, A. A. (2004). The catechol-
O-methyltransferase polymorphism: relations to the tonic-phasic dopamine
hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29,
1943–1961. doi: 10.1038/sj.npp.1300542
Bloem, B., Poorthuis, R. B., and Mansvelder, H. D. (2014). Cholinergic modulation
of the medial prefrontal cortex: the role of nicotinic receptors in attention and
regulation of neuronal activity. Front Neural Circuits 8:17. doi: 10.3389/fncir.
2014.00017
Bozoki, A., Radovanovic, M., Winn, B., Heeter, C., and Anthony, J. C. (2013).
Effects of a computer-based cognitive exercise program on age-related cognitive
decline. Arch. Gerontol. Geriatr. 57, 1–7. doi: 10.1016/j.archger.2013.02.009
Buonomano, D. V., and Merzenich, M. M. (1998). Cortical plasticity: from synapses
to maps. Annu. Rev. Neurosci. 21, 149–186. doi: 10.1146/annurev.neuro.21.1.149
Burhan, A. M., Bartha, R., Bocti, C., Borrie, M., Laforce, R., Rosa-Neto, P., et al.
(2012). Role of emerging neuroimaging modalities in patients with cognitive
impairment: a review from the Canadian Consensus Conference on the Diag-
nosis and Treatment of Dementia. Alzheimers Res. Ther. 5(Suppl. 1):S4. doi: 10.
1186/alzrt200
Chuah, L. Y. M., and Chee, M. W. L. (2008). Cholinergic augmentation modulates
visual task performance in sleep-deprived young adults. J. Neurosci. 28, 11369–
11377. doi: 10.1523/jneurosci.4045-08.2008
Chuah, L. Y., Chong, D. L., Chen, A. K., Rekshan, W. R., Tan, J. C., Zheng, H., et al.
(2009). Donepezil improves episodic memory in young individuals vulnerable
to the effects of sleep deprivation. Sleep 32, 999–1010.
Clark, J. E., Lanphear, A. K., and Riddick, C. C. (1987). The effects of videogame
playing on the response selection processing of elderly adults. J. Gerontol. 42,
82–85. doi: 10.1093/geronj/42.1.82
Coelho, F. G., Gobbi, S., Andreatto, C. A., Corazza, D. I., Pedroso, R. V., and
Santos-Galduróz, R. F. (2013). Physical exercise modulates peripheral levels of
brain-derived neurotrophic factor (BDNF): a systematic review of experimental
studies in the elderly. Arch. Gerontol. Geriatr. 56, 10–15. doi: 10.1016/j.archger.
2012.06.003
Colcombe, S. J., Erickson, K. I., Scalf, P. E., Kim, J. S., Prakash, R., McAuley, E.,
et al. (2006). Aerobic exercise training increases brain volume in aging humans.
J. Gerontol. A Biol. Sci. Med. Sci. 61, 1166–1170. doi: 10.1093/gerona/61.11.1166
Colcombe, S., and Kramer, A. F. (2003). Fitness effects on the cognitive function of
older adults: a meta-analytic study. Psychol. Sci. 14, 125–130. doi: 10.1111/1467-
9280.t01-1-01430
Colcombe, S. J., Kramer, A. F., Erickson, K. I., Scalf, P., McAuley, E., Cohen, N. J.,
et al. (2004). Cardiovascular fitness, cortical plasticity and aging. Proc. Natl.
Acad. Sci. U S A 101, 3316–3321. doi: 10.1073/pnas.0400266101
Cools, R., Frank, M. J., Gibbs, S. E., Miyakawa, A., Jagust, W., and D’Esposito,
M. (2009). Striatal dopamine predicts outcome-specific reversal learning and
its sensitivity to dopaminergic drug administration. J. Neurosci. 29, 1538–1543.
doi: 10.1523/jneurosci.4467-08.2009
Cools, R., Gibbs, S. E., Miyakawa, A., Jagust, W., and D’Esposito, M. (2008).
Working memory capacity predicts dopamine synthesis capacity in the human
striatum. J. Neurosci. 28, 1208–1212. doi: 10.1523/JNEUROSCI.4475-07.2008
Cools, R., Sheridan, M., Jacobs, E., and D’Esposito, M. (2007). Impulsive per-
sonality predicts dopamine-dependent changes in frontostriatal activity during
component processes of working memory. J. Neurosci. 27, 5506–5514. doi: 10.
1523/jneurosci.0601-07.2007
Corbetta, M., Patel, G., and Shulman, G. L. (2008). The reorienting system of the
human brain: from environment to theory of mind.Neuron 58, 306–324. doi: 10.
1016/j.neuron.2008.04.017
Curlik, D. M., and Shors, T. J. (2013). Training your brain: do mental and physical
(MAP) training enhance cognition through the process of neurogenesis in
the hippocampus? Neuropharmacology 64, 506–514. doi: 10.1016/j.neuropharm.
2012.07.027
Davis, S. W., Dennis, N. A., Daselaar, S. M., Fleck, M. S., and Cabeza, R. (2008).
Que PASA? The posterior-anterior shift in aging. Cereb. Cortex 18, 1201–1209.
doi: 10.1093/cercor/bhm155
Frontiers in Systems Neuroscience www.frontiersin.org September 2014 | Volume 8 | Article 153 | 7
Pieramico et al. Brain aging cognitive enhancement
Davis, S. W., Kragel, J. E., Madden, D. J., and Cabeza, R. (2012). The architecture
of cross-hemispheric communication in the aging brain: linking behavior to
functional and structural connectivity. Cereb. Cortex 22, 232–242. doi: 10.
1093/cercor/bhr123
Deslandes, A., Moraes, H., Ferreira, C., Veiga, H., Silveira, H., Mouta, R., et al.
(2009). Exercise and mental health: many reasons to move. Neuropsychobiology
59, 191–198. doi: 10.1159/000223730
Dresler, M., Sandberg, A., Ohla, K., Bublitz, C., Trenado, C., Mroczko-Wasowicz,
A., et al. (2013). Non-pharmacological cognitive enhancement. Neuropharma-
cology 64, 529–543. doi: 10.1016/j.neuropharm.2012.07.002
Dunbar, G. C., Inglis, F., Kuchibhatla, R., Sharma, T., Tomlinson, M., and Wamsley,
J. (2007). Effect of ispronicline, a neuronal nicotinic acetylcholine receptor
partial agonist, in subjects with age associated memory impairment (AAMI).
J. Psychopharmacol. 21, 171–178. doi: 10.1177/0269881107066855
Dustman, R. E., Emmerson, R. Y., Steinhaus, L. A., Shearer, D. E., and Dustman,
T. J. (1992). The effects of videogame playing on neuropsychological perfor-
mance of elderly individuals. J. Gerontol. 47, 168–171. doi: 10.1093/geronj/47.3.
p168
Edgar, D. M., and Seidel, W. F. (1997). Modafinil induces wakefulness without
intensifying motor activity or subsequent rebound hypersomnolence in the rat.
J. Pharmacol. Exp. Ther. 283, 757–769.
Elliott, R., Sahakian, B. J., Matthews, K., Bannerjea, A., Rimmer, J., and Robbins,
T. W. (1997). Effects of methylphenidate on spatial working memory and
planning in healthy young adults. Psychopharmacology (Berl) 131, 196–206.
doi: 10.1007/s002130050284
Engvig, A., Fjell, A. M., Westlye, L. T., Moberget, T., Sundseth, Ø., Larsen, V. A.,
et al. (2010). Effects of memory training on corticalthickness in the elderly.
Neuroimage 52, 1667–1676. doi: 10.1016/j.neuroimage.2010.05.041
Engvig, A., Fjell, A. M., Westlye, L. T., Skaane, N. V., Dale, A. M., Holland, D., et al.
(2014). Effects of cognitive training on gray matter volumes in memory clinic
patients with subjective memory impairment. J. Alzheimers Dis. 41, 779–791.
doi: 10.3233/JAD-131889
Engvig, A., Fjell, A. M., Westlye, L. T., Skaane, N. V., Sundseth, Ø., and Walhovd,
K. B. (2012). Hippocampal subfield volumes correlate with memory training
benefit in subjective memory impairment. Neuroimage 61, 188–194. doi: 10.
1016/j.neuroimage.2012.02.072
Erickson, K. I., Gildengers, A. G., and Butters, M. A. (2013). Physical activity and
brain plasticity in late adulthood. Dialogues Clin. Neurosci. 15, 99–108.
Erickson, K. I., Raji, C. A., Lopez, O. L., Becker, J. T., Rosano, C., Newman, A. B.,
et al. (2010). Physical activity predicts grey matter volume in late adulthood:
the Cardiovascular Health Study. Neurology 75, 1415–1422. doi: 10.1212/wnl.
0b013e3181f88359
Erickson, K. I., Voss, M. W., Prakash, R. S., Basak, C., Szabo, A., Chaddock, L.,
et al. (2011). Exercise training increases size of hippocampus and improves
memory. Proc. Natl. Acad. Sci. U S A 108, 3017–3022. doi: 10.1073/pnas.10159
50108
Esposito, R., Cilli, F., Pieramico, V., Ferretti, A., Macchia, A., Tommasi, M., et al.
(2013). Acute effects of modafinil on brain resting state networks in young
healthy subjects. PLoS One 8:e69224. doi: 10.1371/journal.pone.0069224
Fabre, C., Chamari, K., and Mucci, P. (2002). Improvement of cognitive function
via mental and/or individualised aerobic training in healthy elderly subject. Int.
J. Sports Med. 23, 415–421. doi: 10.1055/s-2002-33735
Feldman, D. E. (2009). Synaptic mechanisms for plasticity in neocortex. Annu. Rev.
Neurosci. 32, 33–55. doi: 10.1146/annurev.neuro.051508.135516
Feldman, D. E., and Brecht, M. (2005). Map plasticity in somatosensory cortex.
Science 310, 810–815. doi: 10.1126/science.1115807
Finke, K., Dodds, C. M., Bublak, P., Regenthal, R., Baumann, F., Manly, T.,
et al. (2010). Effects of modafinil and methylphenidate on visual attention
capacity: a TVA-based study. Psychopharmacology (Berl) 210, 317–329. doi: 10.
1007/s00213-010-1823-x
Fjell, A. M., McEvoy, L., Holland, D., Dale, A. M., and Walhovd, K. B. (2014).
Alzheimer’s disease neuroimaging initiative. What is normal in normal aging?
Effects of aging, amyloid and Alzheimer’s disease on the cerebral cortex and
the hippocampus. Prog. Neurobiol. 117, 20–40. doi: 10.1016/j.pneurobio.2014.
02.004
Frank, M. J., and O’Reilly, R. C. (2006). A mechanistic account of striatal dopamine
function in human cognition: psychopharmacological studies with cabergoline
and haloperidol. Behav. Neurosci. 120, 497–517. doi: 10.1037/0735-7044.120.
3.497
Fratiglioni, L., Paillard-Borg, S., and Winblad, B. (2004). An active and socially
integrated lifestyle in late life might protect against dementia. Lancet Neurol.
3, 343–353. doi: 10.1016/s1474-4422(04)00767-7
Friedland, R. P., Brun, A., and Budinger, T. F. (1985). Pathological and positron
emission tomographic correlations in Alzheimer’s disease. Lancet 1, 228. doi: 10.
1016/s0140-6736(85)92074-4
Ganguly, K., and Poo, M. M. (2013). Activity-dependent neural plasticity from
bench to bedside. Neuron 80, 729–741. doi: 10.1016/j.neuron.2013.10.028
Gibbs, S. E. B., and D’Esposito, M. (2005). Individual capacity differences predict
working memory performance and prefrontal activity following dopamine
receptor stimulation. Cogn. Affect Behav. Neurosci. 5, 212–221. doi: 10.
3758/cabn.5.2.212
Gibbs, S. E., and D’Esposito, M. (2006). A functional magnetic resonance imaging
study of the effects of pergolide, a dopamine receptor agonist, on compo-
nent processes of working memory. Neuroscience 139, 359–371. doi: 10.1016/j.
neuroscience.2005.11.055
Goldstein, J., Cajko, L., Oosterbroek, M., Michielsen, M., and Van Houten, O.
(1997). Video game and the elderly. Soc. Behav. Pers. Int. J. 25, 345–352.
Green, C. S., and Bavelier, D. (2008). Exercising your brain: a review of human brain
plasticity and training-induced learning. Psychol. Aging 23, 692–701. doi: 10.
1037/a0014345
Grefkes, C., and Ward, N. S. (2014). Cortical reorganization after stroke: how
much and how functional? Neuroscientist 20, 56–70. doi: 10.1177/10738584134
91147
Hampson, R. E., España, R. A., Rogers, G. A., Porrino, L. J., and Deadwyler,
S. A. (2009). Mechanisms underlying cognitive enhancement and reversal of
cognitive deficits in nonhuman primates by the ampakine CX717. Psychophar-
macology (Berl) 202, 355–369. doi: 10.1007/s00213-008-1360-z
Hannestad, J., Gallezot, J. D., Planeta-Wilson, B., Lin, S. F., Williams, W. A., van
Dyck, C. H., et al. (2010). Clinically relevant doses of methylphenidate signifi-
cantly occupy norepinephrine transporters in humans in vivo. Biol. Psychiatry
68, 854–860. doi: 10.1016/j.biopsych.2010.06.017
Howe, W. M., Ji, J., Parikh, V., Williams, S., Mocaër, E., Trocmé-Thibierge, C., et al.
(2010). Enhancement of attentional performance by selective stimulation of
alpha4beta2(*) nAChRs: underlying cholinergic mechanisms. Neuropsychophar-
macology 35, 1391–1401. doi: 10.1038/npp.2010.9
Hurd, M. D., Martorell, P., and Langa, K. M. (2013). Monetary costs of dementia
in the United States. N. Engl. J. Med. 369, 489–490. doi: 10.1056/nejmc130
5541
Hussain, M., and Mehta, M. A. (2011). Cognitive enhancement by drugs in health
and disease. Trends Cogn. Sci. 15, 28–36. doi: 10.1016/j.tics.2010.11.002
Ishizuka, T., Murotani, T., and Yamatodani, A. (2010). Modanifil activates the
histaminergic system through the orexinergic neurons. Neurosci. Lett. 483, 193–
196. doi: 10.1016/j.neulet.2010.08.005
Jack, A. J. (2011). The impact of physical and mental activity on cognitive aging.
Curr. Top. Behav. Neurosci. 10, 273–291. doi: 10.1007/7854_2011_141
Jaeggi, S. M., Buschkuehl, M., Jonides, J., and Perrig, W. J. (2008). Improving fluid
intelligence with training on working memory. Proc. Natl. Acad. Sci. U S A 105,
6829–6833. doi: 10.1073/pnas.0801268105
Jiang, L., and Role, L. W. (2008). Facilitation of cortico-amygdala synapses by
nicotine: activitydependent modulation of glutamatergic transmission. J. Neu-
rophysiol. 99, 1988–1999. doi: 10.1152/jn.00933.2007
Kerr, A. L., Steuer, E. L., Pochtarev, V., and Swain, R. A. (2010). Angiogenesis
but not neurogenesis is critical for normal learning and memory acquisition.
Neuroscience 171, 214–226. doi: 10.1016/j.neuroscience.2010.08.008
Kimberg, D. Y., D’Esposito, M., and Farah, M. J. (1997). Effects of bromocriptine
on human subjects depend on working memory capacity. Neuroreport 8, 3581–
3585. doi: 10.1097/00001756-199711100-00032
Klusmann, V., Evers, A., Schwarzer, R., Schlattmann, P., Reischies, F. M., Heuser,
I., et al. (2010). Complex mental and physical activity in older women and
cognitive performance: a 6-month randomized controlled trial. J. Gerontol. A
Biol. Sci. Med. Sci. 65, 680–688. doi: 10.1093/gerona/glq053
Kramer, A. F., Colcombe, S. J., McAuley, E., Eriksen, K. I., Scalf, P., Jerome, G. J.,
et al. (2003). Enhancing brain and cognitive function of older adults through
fitness training. J. Mol. Neurosci. 20, 213–221. doi: 10.1385/jmn:20:3:213
Lanni, C., Racchi, M., Uberti, D., Mazzini, G., Stanga, S., Sinforiani, E., et al.
(2008). Pharmacogenetics and pharmagenomics, trends in normal and patho-
logical aging studies: focus on p53. Curr. Pharm. Des. 14, 2665–2671. doi: 10.
2174/138161208786264133
Frontiers in Systems Neuroscience www.frontiersin.org September 2014 | Volume 8 | Article 153 | 8
Pieramico et al. Brain aging cognitive enhancement
Lauterborn, J. C., Lynch, G., Vanderklish, P., Arai, A., and Gall, C. M. (2000).
Positive modulation of AMPA receptors increases neurotrophin expression by
hippocampal and cortical neurons. J. Neurosci. 20, 8–21.
Lauterborn, J. C., Truong, G. S., Baudry, M., Bi, X., Lynch, G., and Gall, C. M.
(2003). Chronic elevation of brain-derived neurotrophic factor by ampakines.
J. Pharmacol. Exp. Ther. 307, 297–305. doi: 10.1124/jpet.103.053694
Legutko, B., Li, X., and Skolnick, P. (2001). Regulation of BDNF expres-
sion in primary neuron culture by LY392098, a novel AMPA receptor
potentiator. Neuropharmacology 40, 1019–1027. doi: 10.1016/s0028-3908(01)
00006-5
Loughead, J., Ray, R., Wileyto, E. P., Ruparel, K., Sanborn, P., Siegel, S., et al.
(2010). Effects of the alpha4beta2 partial agonist varenicline on brain activity
and working memory in abstinent smokers. Biol. Psychiatry 67, 715–721. doi: 10.
1016/j.biopsych.2010.01.016
Lynch, G. (2002). Memory enhancement: the search for mechanism-based drugs.
Nat. Neurosci. 5(Suppl. 1), 1035–1038. doi: 10.1038/nn935
Lynch, G. (2004). AMPA receptor modulators as cognitive enhancers. Curr. Opin.
Pharmacol. 4, 4–11. doi: 10.1016/j.coph.2003.09.009
Lynch, G., and Gall, C. M. (2006). Ampakines and the threefold path to cog-
nitive enhancement. Trends Neurosci. 29, 554–562. doi: 10.1016/j.tins.2006.
07.007
Lynch, M. A., and Mills, K. H. (2012). Immunology meets neuroscience–
opportunities for immune intervention in neurodegenerative diseases. Brain
Behav. Immun. 26, 1–10. doi: 10.1016/j.bbi.2011.05.013
Lynch, G., Palmer, L. C., and Gall, C. M. (2011). The likelihood of cognitive
enhancement. Pharmacol. Biochem. Behav. 99, 116–129. doi: 10.1016/j.pbb.
2010.12.024
Madras, B. K., Xie, Z., Lin, Z., Jassen, A., Panas, H., Lynch, L., et al. (2006).
Modafinil occupies dopamine and norepinephrine transporters in vivo and
modulates the transporters and trace amine activity in vitro. J. Pharmacol. Exp.
Ther. 319, 561–569. doi: 10.1124/jpet.106.106583
Maillot, P., Perrot, A., and Hartley, A. (2012). Effects of interactive physical-activity
video-game training on physical and cognitive function in older adults. Psychol.
Aging 27, 589–600. doi: 10.1037/a0026268
Marchant, N. L., King, S. L., Tabet, N., and Rusted, J. M. (2010). Positive effects of
cholinergic stimulation favor young APOE epsilon4 carriers. Neuropsychophar-
macology 35, 1090–1096. doi: 10.1038/npp.2009.214
McGeer, E. G., Peppard, R. P., McGeer, P. L., Tuokko, H., Crockett, D., Parks, R.,
et al. (1990). 18Fluorodeoxyglucose positron emission tomography studies in
presumed Alzheimer cases, including 13 serial scans. Can. J. Neurol. Sci. 17,
1–11.
Mehta, M. A., Owen, A. M., Sahakian, B. J., Mavaddat, N., Pickard, J. D., and
Robbins, T. W. (2000). Methylphenidate enhances working memory by modu-
lating discrete frontal and parietal lobe regions in the human brain. J. Neurosci.
20:RC65.
Middleton, L. E., Barnes, D. E., Lui, L. Y., and Yaffe, K. (2010). Physical activity over
the life course and its association with cognitive performance and impairment
in old age. J. Am. Geriatr. Soc. 58, 1322–1326. doi: 10.1111/j.1532-5415.2010.
02903.x
Miller, K. J., Dye, R. V., Kim, J., Jennings, J. L., O’Toole, E., Wong, J., et al. (2013).
Effect of a computerized brain exercise program on cognitive performance in
older adults. Am. J. Geriatr. Psychiatry 21, 655–663. doi: 10.1016/j.jagp.2013.
01.077
Minzenberg, M. J., and Carter, C. S. (2008). Modafinil: a review of neurochemical
actions and effects on cognition. Neuropsychopharmacology 33, 1477–1502.
doi: 10.1038/sj.npp.1301534
Mora, F. (2013). Successful brain aging: plasticity, environmental enrichment and
lifestyle. Dialogues Clin. Neurosci. 15, 45–52.
Mozolic, J. L., Long, A. B., Morgan, A. R., Rawley-Payne, M., and Laurienti, P. J.
(2011). A cognitive training intervention improves modality-specific attention
in a randomized controlled trial of healthy older adults. Neurobiol. Aging 32,
655–668. doi: 10.1016/j.neurobiolaging.2009.04.013
Muller, U., Steffenhagen, N., Regenthal, R., and Bublak, P. (2004). Effects of
modafinil on working memory processes in humans. Psychopharmacology (Berl)
177, 161–169. doi: 10.1007/s00213-004-1926-3
Nouchi, R., Taki, Y., Takeuchi, H., Hashizume, H., Nozawa, T., Kambara, T., et al.
(2012). Brain training game improves executive functions and processing speed
in the elderly: a randomized controlled trial. PLoS One 7:e29676. doi: 10.
1371/journal.pone.0029676
O’Neill, M. J., Bleakman, D., Zimmerman, D. M., and Nisenbaum, E. S.
(2004). AMPA receptor potentiators for the treatment of CNS disorders.
Curr. Drug Targets CNS Neurol. Disord. 3, 181–194. doi: 10.2174/15680070433
37508
O’Neill, M. J., Murray, T. K., Clay, M. P., Lindstrom, T., Yang, C. R., and Nisenbaum,
E. S. (2005). LY503430: pharmacology, pharmacokinetics and effects in rodent
models of Parkinson’s disease. CNS Drug Rev. 11, 77–96. doi: 10.1111/j.1527-
3458.2005.tb00037.x
Oswald, W., Gunzelmann, T., Rupprecht, R., and Hagen, B. (2006). Differential
effects of single versus combined cognitive and physical training with older
adults: the SimA study in a 5-year perspective. Eur. J. Ageing 3, 179–192. doi: 10.
1007/s10433-006-0035-z
Park, D. C., and Bischof, G. N. (2013). The aging mind: neuroplasticity in response
to cognitive training. Dialogues Clin. Neurosci. 15, 109–119. doi: 10.1016/b978-
0-12-380882-0.00007-3
Pascual-Leone, A., Amedi, A., Fregni, F., and Merabet, L. B. (2005). The plastic
human brain cortex. Annu. Rev. Neurosci. 28, 377–401. doi: 10.1016/j.cortex.
2014.06.001
Peretz, C., Korczyn, A. D., Shatil, E., Aharonson, V., Birnboim, S., and Giladi,
N. (2011). Computer-based, personalized cognitive training versus classical
computer games: a randomized double-blind prospective trial of cognitive
stimulation. Neuroepidemiology 36, 91–99. doi: 10.1159/000323950
Pieramico, V., Esposito, R., Sensi, F., Cilli, F., Mantini, D., Mattei, P. A., et al. (2012).
Combination training in aging individuals modifies functional connectivity
and cognition and is potentially affected by dopamine-related genes. PLoS One
7:e43901. doi: 10.1371/journal.pone.0043901
Porrino, L. J., Daunais, J. B., Rogers, G. A., Hampson, R. E., and Deadwyler, S. A.
(2005). Facilitation of task performance and removal of the effects of sleep
deprivation by an ampakine (CX717) in nonhuman primates. PLoS Biol. 3:e299.
doi: 10.1371/journal.pbio.0030299
Pozo, K., and Goda, Y. (2010). Unraveling mechanisms of homeostatic synaptic
plasticity. Neuron 66, 337–351. doi: 10.1016/j.neuron.2010.04.028
Raichle, M. E., and Mintun, M. A. (2006). Brain work and brain imaging. Annu.
Rev. Neurosci. 29, 449–476. doi: 10.1146/annurev.neuro.29.051605.112819
Randall, D. C., Shneerson, J. M., and File, S. E. (2005). Cognitive effects of modafinil
in student volunteers may depend on IQ. Pharmacol. Biochem. Behav. 82, 133–
139. doi: 10.1016/j.pbb.2005.07.019
Raschetti, R., Albanese, E., Vanacore, N., and Maggini, M. (2007). Cholinesterase
inhibitors in mild cognitive impairment: a systematic review of randomised
trials. PLoS Med. 4:e338. doi: 10.1371/journal.pmed.0040338
Richmond, L. L., Morrison, A. B., Chein, J. M., and Olson, I. R. (2011). Working
memory training and transfer in older adults. Psychol. Aging 26, 813–822.
doi: 10.1037/a0023631
Roesler, R. (2011). Cognitive enhancers: focus on modulatory signaling influencing
memory consolidation. Pharmacol. Biochem. Behav. 99, 155–163. doi: 10.1016/j.
pbb.2010.12.028
Roses, A. D. (2008). Pharmacogenetics in drug discovery and development: a
translational perspective. Nat. Rev. Drug Discov. 7, 807–817. doi: 10.1038/
nrd2593
Sarter, M. (2006). Preclinical research into cognition enhancers. Trends Pharmacol.
Sci. 27, 602–608. doi: 10.1016/j.tips.2006.09.004
Scarmeas, N., Zarahn, E., Anderson, K. E., Habeck, C. G., Hilton, J., Flynn, J.,
et al. (2003). Association of life activities with cerebral blood flow in Alzheimer
disease: implications for the cognitive reserve hypothesis. Arch. Neurol. 60, 359–
365. doi: 10.1001/archneur.60.3.359
Schitine, C., Xapelli, S., Agasse, F., Sardà-Arroyo, L., Silva, A. P., De Melo Reis,
R. A., et al. (2012). Ampakine CX546 increases proliferation and neuronal
differentiation in subventricular zone stem/progenitor cell cultures. Eur. J.
Neurosci. 35, 1672–1683. doi: 10.1111/j.1460-9568.2012.08072.x
Schneider, N., and Yvon, C. (2013). A review of multidomain interventions to
support healthy cognitive ageing. J. Nutr. Health Aging 17, 252–257. doi: 10.
1007/s12603-012-0402-8
Shatil, E. (2013). Does combined cognitive training and physical activity training
enhance cognitive abilities more than either alone? A four-condition random-
ized controlled trial among healthy older adults. Front. Aging Neurosci. 5:8.
doi: 10.3389/fnagi.2013.00008
Simon, P., Hémet, C., Ramassamy, C., and Costentin, J. (1995). Non-amphetaminic
mechanism of stimulant locomotor effect of modafinil in mice. Eur. Neuropsy-
chopharmacol. 5, 509–514. doi: 10.1016/0924-977x(95)00041-m
Frontiers in Systems Neuroscience www.frontiersin.org September 2014 | Volume 8 | Article 153 | 9
Pieramico et al. Brain aging cognitive enhancement
Simpson, T., Camfield, D., Pipingas, A., Macpherson, H., and Stough, C.
(2012). Improved processing speed: online computer-based cognitive train-
ing in older adults. Educ. Gerontol. 38, 445–458. doi: 10.1080/03601277.2011.
559858
Smith, P. J., Blumenthal, J. A., Hoffman, B. M., Cooper, H., Strauman, T. A., Welsh-
Bohmer, K., et al. (2010). Aerobic exercise and neurocognitive performance: a
meta-analytic review of randomized controlled trials. Psychosom. Med. 72, 239–
252. doi: 10.1097/psy.0b013e3181d14633
Stern, Y. (2009). Cognitive reserve. Neuropsychologia 47, 2015–2028. doi: 10.1016/j.
neuropsychologia.2009.03.004
Stern, Y., Alexander, G. E., Prohovnik, I., Stricks, L., Link, B., Lennon, M. C.,
et al. (1995). Relationship between lifetime occupation and parietal flow:
implications for a reserve against Alzheimer’s disease pathology. Neurology 45,
55–60. doi: 10.1212/wnl.45.1.55
Stern, Y., Habeck, C., Moeller, J., Scarmeas, N., Anderson, K. E., Hilton, H. J., et al.
(2005). Brain networks associated with cognitive reserve in healthy young and
old adults. Cereb. Cortex 15, 394–402. doi: 10.1093/cercor/bhh142
Stone, E. A., Cotecchia, S., Lin, Y., and Quartermain, D. (2002). Role of brain alpha
1B-adrenoceptors in modafinil-induced behavioral activity. Synapse 46, 269–
270. doi: 10.1002/syn.10127
Szelag, E., and Skolimowska, J. (2012). Cognitive function in elderly can be
ameliorated by training in temporal information processing. Restor. Neurol.
Neurosci. 30, 419–434. doi: 10.3233/RNN-2012-120240
Turner, D. C., Robbins, T. W., Clark, L., Aron, A. R., Dowson, J., and Sahakian,
B. J. (2003). Cognitive enhancing effects of modafinil in healthy volunteers.
Psychopharmacology (Berl) 165, 260–269.
Urban, K. R., and Gao, W. J. (2014). Performance enhancement at the cost
of potential brain plasticity: neural ramifications of nootropic drugs in the
healthy developing brain. Front. Syst. Neurosci. 8:38. doi: 10.3389/fnsys.2014.
00038
Vallesi, A., McIntosh, A. R., and Stuss, D. T. (2011). Overrecruitment in the aging
brain as a function of task demands: evidence for a compensatory view. J. Cogn.
Neurosci. 23, 801–815. doi: 10.1162/jocn.2010.21490
van Praag, H., Kempermann, G., and Gage, F. H. (2000). Neural conse-
quences of environmental enrichment. Nat. Rev. Neurosci. 1, 191–198. doi: 10.
1038/35044558
Vaughan, S., Morris, N., Shum, D., O’Dwyer, S., and Polit, D. (2012). Study
protocol: a randomised controlled trial of the effects of a multi-modal exercise
program on cognition and physical functioning in older women. BMC Geriatr.
12:60. doi: 10.1186/1471-2318-12-60
Vincent, J. L., Kahn, I., Snyder, A. Z., Raichle, M. E., and Buckner, R. L. (2008).
Evidence for a frontoparietal control system revealed by intrinsic functional
connectivity. J. Neurophysiol. 100, 3328–3342. doi: 10.1152/jn.90355.2008
Volkow, N. D., Fowler, J. S., Logan, J., Alexoff, D., Zhu, W., Telang, F., et al. (2009).
Effects of modafinil on dopamine and dopamine transporters in the male
human brain: clinical implications. JAMA 301, 1148–1154. doi: 10.1001/jama.
2009.351
Volkow, N. D., Wang, G. J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y. S., et al.
(1998). Dopamine transporter occupancies in the human brain induced by
therapeutic doses of oral methylphenidate. Am. J. Psychiatry. 155, 1325–1331.
Voss, M. W., Vivar, C., Kramer, A. F., and van Praag, H. (2013). Bridging animal
and human models of exercise-induced brain plasticity. Trends Cogn. Sci. 17,
525–544. doi: 10.1016/j.tics.2013.08.001
Wezenberg, E., Verkes, R. J., Ruigt, G. S., Hulstijn, W., and Sabbe, B. G.
(2007). Acute effects of the ampakinefarampator on memory and information
processing in healthy elderly volunteers. Neuropsychopharmacology 32, 1272–
1283. doi: 10.1038/sj.npp.1301257
Wezenberg, E., Verkes, R. J., Sabbe, B. G., Ruigt, G. S., and Hulstijn, W.
(2005). Modulation of memory and visuospatial processes by biperiden and
rivastigmine in elderly healthy subjects. Psychopharmacology (Berl) 181, 582–
594. doi: 10.1007/s00213-005-0083-7
Whitlock, L. A., Collins, A. C., and Allaire, J. C. (2012). Individual differences in
response to cognitive training: using a multi-modal, attentionally demanding
game-based intervention for older adults. Comput. Human Behav. 28, 1091–
1096. doi: 10.1016/j.chb.2012.01.012
Wild-Wall, N., Falkenstein, M., and Gajewski, P. D. (2012). Neural correlates of
changes in a visual search task due to cognitive training in seniors. Neural Plast.
2012:529057. doi: 10.1155/2012/529057
Wilson, R. S., Li, Y., Aggarwal, N. T., Barnes, L. L., McCann, J. J., Gilley, D. W.,
et al. (2004). Education and the course of cognitive decline in Alzheimer disease.
Neurology 63, 1198–1202. doi: 10.1212/01.wnl.0000140488.65299.53
Wittenberg, G. F. (2010). Experience, cortical remapping and recovery in brain
disease. Neurobiol. Dis. 37, 252–258. doi: 10.1016/j.nbd.2009.09.007
Wood, S., Sage, J. R., Shuman, T., and Anagnostaras, S. G. (2013). Psychostimulants
and cognition: a continuum of behavioral and cognitive activation. Pharmacol.
Rev. 66, 193–221. doi: 10.1124/pr.112.007054
Xerri, C. (2008). Imprinting of idiosyncratic experience in cortical sensory maps:
neural substrates of representational remodeling and correlative perceptual
changes. Behav. Brain Res. 192, 26–141. doi: 10.1016/j.bbr.2008.02.038
Yerkes, R. M., and Dodson, J. D. (1908). The relation of strength of stimulus to
rapidity of habit-formation. J. Comp. Neurol. Psychol. 18, 459–482. doi: 10.
1002/cne.920180503
Yesavage, J. A., Mumenthaler, M. S., Taylor, J. L., Friedman, L., O’Hara, R., Sheikh,
J., et al. (2002). Donepezil and flight simulator performance: effects on retention
of complex skills. Neurology 59, 123–125. doi: 10.1212/wnl.59.1.123
Zelinski, E. M., Spina, L. M., Yaffe, K., Ruff, R., Kennison, R. F., Mahncke, H. W.,
et al. (2011). Improvement in memory with plasticity-based adaptive cognitive
training: results of the 3-month follow-up. J. Am. Geriatr. Soc. 59, 258–265.
doi: 10.1111/j.1532-5415.2010.03277.x
Zolkowska, D., Jain, R., Rothman, R. B., Partilla, J. S., Roth, B. L., Setola, V., et al.
(2009). Evidence for the involvement of dopamine transporters in behavioral
stimulant effects of modafinil. J. Pharmacol. Exp. Ther. 329, 738–746. doi: 10.
1124/jpet.108.146142
Conflict of Interest Statement: The authors declare that the research was conducted
in the absence of any commercial or financial relationships that could be construed
as a potential conflict of interest.
Received: 25 June 2014; accepted: 05 August 2014; published online: 02 September
2014.
Citation: Pieramico V, Esposito R, Cesinaro S, Frazzini V and Sensi SL (2014) Effects
of non-pharmacological or pharmacological interventions on cognition and brain plas-
ticity of aging individuals. Front. Syst. Neurosci. 8:153. doi: 10.3389/fnsys.2014.00153
This article was submitted to the journal Frontiers in Systems Neuroscience.
Copyright © 2014 Pieramico, Esposito, Cesinaro, Frazzini and Sensi. This is an open-
access article distributed under the terms of the Creative Commons Attribution License
(CC BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Systems Neuroscience www.frontiersin.org September 2014 | Volume 8 | Article 153 | 10
